A clinical trial to study the frequency of genetic variations which influence the harmful levels of lead and mercury in children with the brain disorder called cerebral palsy.
Not Applicable
- Conditions
- Health Condition 1: null- Cerebral palsy
- Registration Number
- CTRI/2011/10/002036
- Lead Sponsor
- Dr Y K GUPTA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
Chidren aged 2-12 years with cerebral palsy attending Pediatric Neurology Outpatient department,All India Institute of Medical Sciences, NewDelhi.
Exclusion Criteria
1.Progressive neurodegenerative disorders
2.Severe systemic illness with multiple organ dysfunctions
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The blood levels of lead and mercury will increase with the increase in frequency of ALAD2 and CPOX4 variants respectively in cerebral palsy children when compared to control children.Timepoint: Not applicable
- Secondary Outcome Measures
Name Time Method The frequency of factor V Leiden and Methylenetetrahydrofolate reductase gene polymorphism C677T will increase in cerebral palsy children when compared to control children.Timepoint: Not applicable